Delorean Corporation Ltd AI Stock Analysis
Want to see AU:DEL full AI Analyst Report?
Delorean Corporation Ltd (DEL) AI Stock Analysis
Delorean Corporation Ltd
(ASX:DEL)
The overall score is extremely low, driven primarily by a severe financial deterioration that threatens the company's viability. Collapsing revenues, deep negative gross margins, and a massive cash burn are compounded by an unsustainable debt load. The weak technical trend and negative valuation metrics reinforce the poor outlook, leaving no positive catalysts to offset the risks.
Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 18.98M
- Dividend Yield
- ―
- Average Volume (3M)
- 103.89K
- Price to Earnings (P/E)
- -17.6
- Beta (1Y)
- 0.13
- Revenue Growth
- -52.16%
- EPS Growth
- 96.81%
- Country
- Australia
- Employees
- 28
- Sector
- Utilities
- Sector Strength
- 66
- Industry
- Renewable Utilities
Delorean Corporation Ltd Business Overview & Revenue Model
Company Description
Delorean Corporation Limited is an Australian enterprise deeply involved in the renewable energy and waste management industries across both Australia and New Zealand. Its comprehensive business model is segmented into Infrastructure, Engineering, En...
How the Company Makes Money
Delorean Corporation’s revenue model is based on monetising biogas and the energy and environmental attributes derived from it. Key revenue streams include: (1) electricity generation revenue from converting captured biogas into power and selling tha...
Delorean Corporation Ltd Financial Statement Overview
Summary
Financial health is critically poor. Revenue collapsed 40% to $8.5M, gross margins are deeply negative at -38%, and the balance sheet is saddled with $49.9M in debt against only $7.5M in equity. Free cash flow is a massive -$22.8M, indicating a severe cash burn that threatens solvency.
Income Statement
8Very NegativeBalance Sheet
5Very NegativeCash Flow
10Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.54M | 8.54M | 19.83M | 27.88M | 19.25M | 39.33M |
| Gross Profit | -3.25M | -3.25M | -2.99M | 7.83M | -7.18M | -6.77M |
| EBITDA | -4.03M | -4.03M | -6.13M | 5.04M | -9.06M | -11.87M |
| Net Income | -916.03K | -916.03K | -6.55M | 4.77M | -10.02M | -10.89M |
Balance Sheet | ||||||
| Total Assets | 63.97M | 63.97M | 48.30M | 28.05M | 17.92M | 24.10M |
| Cash, Cash Equivalents and Short-Term Investments | 5.41M | 5.41M | 10.66M | 8.84M | 1.00M | 3.12M |
| Total Debt | 49.89M | 49.89M | 31.31M | 9.07M | 7.62M | 2.63M |
| Total Liabilities | 55.66M | 55.66M | 40.45M | 19.28M | 15.75M | 12.21M |
| Stockholders Equity | 8.31M | 8.31M | 7.85M | 8.77M | 2.17M | 11.88M |
Cash Flow | ||||||
| Free Cash Flow | -22.83M | -22.83M | -21.50M | 6.89M | -6.80M | -15.21M |
| Operating Cash Flow | -1.69M | -1.69M | -5.66M | 7.24M | -5.36M | -11.77M |
| Investing Cash Flow | -19.34M | -19.34M | -15.08M | -3.92M | -1.44M | -3.44M |
| Financing Cash Flow | 17.29M | 17.29M | 23.33M | 915.22K | 4.68M | 5.26M |
Delorean Corporation Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DEL, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.09, and below the 200-day MA of 0.09, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 37.68 is Neutral, neither overbought nor oversold. The STOCH value of 24.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DEL.
Delorean Corporation Ltd Peers Comparison
Overall Rating
AU:VPR62.5Neutral
AU:CCE55Neutral
AU:JNS44Neutral
AU:KPO44Neutral
AU:DEL38Underperform
AU:14D37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 66Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |
| 63Neutral | AUD 17.94M | 9.91 | 12.83% | ― | 57.73% | 30.59% | |
| 55Neutral | AUD 72.64M | -24.29 | -14.42% | ― | 42.98% | -9.38% | |
| 44Neutral | AUD 111.41M | -7.80 | -718.72% | ― | 27.74% | 49.26% | |
| 44Neutral | AUD 33.67M | 2.00 | 65.86% | ― | ― | ― | |
| 38Underperform | AUD 19.72M | -17.56 | -15.03% | ― | -52.16% | 96.81% | |
| 37Underperform | AUD 17.58M | -1.53 | -138.53% | ― | ― | -29.75% |
* Utilities Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:DEL | Delorean Corporation Ltd | 0.07 | -0.08 | -52.00% | |
| AU:CCE | Carnegie Clean Energy Ltd | 0.17 | 0.10 | 129.73% | |
| AU:JNS | ReNu Energy Limited | 0.59 | 0.42 | 247.06% | |
| AU:KPO | Kalina Power Limited | 0.01 | -0.01 | -42.11% | |
| AU:14D | 1414 Degrees Ltd. | 0.02 | 0.00 | 4.35% | |
| AU:VPR | Volt Power Group Ltd | 0.11 | -0.04 | -26.67% |
Delorean Corporation Ltd Corporate Events
Delorean Issues Shares Under Placement and Cleansing Notice
Delorean Corporation Ltd (ASX: DEL) issued 20,895,523 fully paid ordinary shares at $0.067 each under a placement announced on 9 November 2026. The company issued the shares without disclosure under Part 6D.2 and gave a cleansing notice under section...
Delorean Applies to Quote 20,895,523 Fully Paid Ordinary Shares
Delorean Corporation Limited applied for ASX quotation of 20,895,523 fully paid ordinary securities under issuer code DEL. The securities have an issue date of 17 November 2026 and were issued as part of transactions previously announced to the marke...
Delorean Proposes Placement of 20.9 Million Shares
Delorean Corporation Limited lodged an ASX announcement proposing a placement of 20,895,523 fully paid ordinary shares under its DEL security code. The proposed issue, announced on 9 November 2026 and scheduled for 17 November 2026, would expand the...
Delorean Reaches Financial Close on $62.1m Bioenergy Facility
Delorean Corporation operates in Australia’s renewable-energy and bioenergy industry, developing facilities that produce renewable gas for industrial customers. The company reached financial close on its wholly owned $62.1 million Horsley Park Bioene...
Delorean Requests Trading Halt Pending NSW1 Funding Announcement
Delorean Corporation Limited requested a trading halt for its ordinary shares on 5 November 2026, pending an announcement concerning funding for the NSW1 project. The halt is expected to continue until the funding announcement is released or normal t...
Delorean Details ESG Strategy in 2026 Sustainability Report
Delorean Corporation has released a voluntary sustainability report outlining its environmental, social, and governance approach, objectives, priority areas, and progress. The company positions sustainability as central to its operations and as a cat...
Delorean advances flagship bioenergy projects with new funding and regulatory milestones
Delorean reported a quarter-end cash balance of $2.5 million and customer receipts of $0.8 million, while advancing construction of its flagship SA1 Salisbury bioenergy facility to 90% completion. The project secured a key regulatory licence from the...
Delorean sets November date for 2026 AGM and streamlines proxy voting
Delorean Corporation Ltd has scheduled its 2026 Annual General Meeting of shareholders to be held in person at its West Perth premises on 27 November 2026 at 9:00am AWST. Shareholders are directed to access the Notice of Meeting, Explanatory Memorand...
Delorean Calls 2026 AGM, Seeks Director Re-Elections and Share Placement Ratification
Delorean Corporation Ltd has called its annual general meeting for 27 November 2026 in West Perth, setting 25 November 2026 as the record date for shareholder voting. The meeting will review the financial report for the year ended 30 June 2026, inclu...
Delorean Wins Licence for Pioneering SA1 Bioenergy Plant
Delorean Corporation Ltd has secured a key regulatory milestone for its 100% owned SA1 Salisbury Bioenergy Project in South Australia, with the South Australian Environment Protection Authority issuing an operational licence. The facility, about 90%...
Delorean secures Westpac mandate to fund NSW Horsley Park bioenergy project
Delorean Corporation has entered into a non-binding financing agreement and mandate with Westpac Banking Corporation for $20 million to fund capital plant and equipment for its NSW1 Horsley Park Bioenergy Project in Western Sydney. The project, co-lo...
Delorean Corporation Updates Market on Director’s Expired Performance Shares
Delorean Corporation Ltd, an Australian listed company, holds its equity interests through family and superannuation structures associated with director Hamish Jolly, including Dunbar-Harper Pty Ltd and Antediluvian Pty Ltd. The company’s capital str...
Delorean Corporation Cuts Dilution as Over 9 Million Performance Rights Expire
Delorean Corporation Ltd has notified the market of the cessation of a large tranche of performance rights on its register. The company reported that 9,114,476 DELAA performance rights have lapsed, following expiry without being exercised or converte...
Delorean Sets Date and Director Nomination Deadline for 2026 AGM
Delorean Corporation Ltd has scheduled its 2026 Annual General Meeting for 9:00 a.m. AWST on Friday, 27 November 2026, in Perth, and has set 13 October 2026 as the closing date for director nomination submissions. The company will provide further AGM...
Delorean Corporation Lodges Appendix 4G, Confirms Governance Compliance
Delorean Corporation Ltd has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 30 June 2026 is available on its website. The statement, approved by the board as at 30 September 2026, outlines compliance w...
Delorean Details 2026 Corporate Governance Framework and Board Oversight
Delorean Corporation Ltd has detailed its 2026 corporate governance practices, reaffirming a commitment to high standards under the ASX Corporate Governance Principles. The Board’s charter defines responsibilities spanning long-term strategy, financi...
Delorean Targets Emerging Market for Renewable Natural Gas in Australia
Delorean Corporation Ltd operates in Australia’s renewable energy sector, focusing on bioenergy and renewable natural gas. The company is building infrastructure and partnerships to supply lower-carbon gas solutions, targeting hard-to-abate industria...
Delorean and Opal Advance $35m Bioenergy Project at Maryvale Mill
Delorean Corporation and Paper Australia’s Opal have completed the Concept Stage of their collaboration to develop a bioenergy facility at Opal’s Maryvale Mill in Victoria, advancing plans to convert organic residues and paper by-products into renewa...
Delorean advances BOO renewable gas strategy as losses narrow and assets grow
Delorean reported FY26 revenue of $8.5 million, down 56% from FY25, but delivered a positive EBITDA of $0.18 million and cut its total comprehensive loss after tax to $0.9 million, an 86% improvement. Total assets rose to $63 million and cash and ter...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
